.David Crawford, MD, UC San Diego, and Maha H. Hussain, MD, FACP, FASCO, Northwestern Feinberg School of Medicine, discusses darolutamide (Nubeqa) combined with androgen deprivation therapy, with or without docetaxel. #ADT #Urology #Treatment

Christian P. Pavlovich, MD, Johns Hopkins Medicine, provides a detailed overview of serum and urinary #biomarkers for prostate cancer diagnosis and prognosis. #ProstateCancer #Urology #imaging

Grand Rounds Urology hosted @GPohlmanMD for a presentation on how the #OptilumeBPH procedure works and clinical data showing it’s a safe, effective, durable and patient-friendly #BPH treatment option. hubs.li/Q03tf3Z80 #AllAboutTheFlow #urology #Laborie #ProstateHealth #menshealth

.Dr. William Brant, M.D., Veterans Affairs, explores the complexities of medical malpractice and its impact on physicians. #PatientCare #Urology #Practice

.Diane Newman, interviews Ann Stapleton, on the topic of treatment and prevention of recurrent urinary tract infections (#UTI) in women. Check out the rest of the discussion below! 👇 bit.ly/40lBPky #FemaleHealth #Urology #Bladder

Brought to you by Blue Earth Diagnostics: David Crawford, MD, and a PET Tumor Board, present a case of a 55-year-old #ProstateCancer survivor with rising PSA five years after radical prostatectomy. Watch the full discussion below! ⬇️ grandroundsinurology.com/pet-tumor-boar…

.Jay Simhan, MD, MD, FACS, Temple University, explores artificial urinary sphincters in patients with prolonged catheterization, hematuria, and #bladder tumors. #SUI #Functional #Urology

.Jeff Tosoian, MD, MPH, Vanderbilt Health, introduces the MyProstateScore 2.0 test as a non-invasive urine-based diagnostic tool for #ProstateCancer. #Urology #diagnostics #biomarkers

GRU Need to Know: David Crawford, MD and Steven Stone, PhD, discuss Simon criteria for biomarkers, particularly in urologic #oncology. #ProstateCancer #Urology #Biomarkers

.Gopal Iyer, Memorial Sloan Kettering Cancer Center, explores the evolving role of immunotherapy in upper tract urothelial carcinoma (UTUC), emphasizing molecular distinctions from #BladderCancer. #UTUC #Immunotherapy #Urology

Tiffany Ly, MPAS, PA-C, AZ Urogynecology, focuses on practical principles for interpreting radiologic #imaging in urology. #APP #Urology #Radiology

.Katie Amin, MD, FRCSC, Desai Sethi Urology Institute, updates on managing neurogenic bladder, focusing on guidelines, risk stratification, and treatment strategies. #Neurogenic #Bladder #Urology

.Dr. David Albala, Crouse Health, explores surgical strategies and diagnostic tools for managing #ProstateCancer, while emphasizing techniques to improve nerve sparing and reduce positive surgical margins. #AI #Imaging #Urology

.Dr_KevinZorn, BPH Canada Prostate Institute, discusses the management of obstructive lower urinary tract symptoms (#LUTS) in men with prostate cancer. #ProstateCancer #Urology #MensHealth

Mark Emberton, MD, UCL Medical School, discusses the evolving roles of active surveillance and #focaltherapy in managing prostate cancer. #Imaging #ProstateCancer #Urology

.Andrew Vickers, Weill Cornell Medicine, discusses the need for reforming the Gleason score, the cornerstone of decision-making in #ProstateCancer management. #Gleason #biopsy #Urology

.David Crawford, MD, presents a case involving a 72-year-old with a rising PSA and suspicious #MRI findings (PI-RADS 4–5) to an expert PET Tumor Board. Watch the full discussion below! ⬇️ grandroundsinurology.com/pet-tumor-boar… Brought to you by Blue Earth Diagnostics.

Leonard G. Gomella, MD, FACS, Jefferson Urology, and Brian Helfand MD, PhD, MD, PhD, Endeavor Health, discuss genetic testing in prostate cancer risk assessment and management. #Genetic #ProstateCancer #Urology

.Dr_KevinZorn, BPH Canada Prostate Institute, explores the evolving approaches to treating benign prostatic hyperplasia (#BPH). #ProstateCancer #Urology #MensHealth